Bio-Rad Laboratories, Inc. which can be found using ticker (BIO) have now 5 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between 605 and 525 calculating the mean target price we have $569.20. Now with the previous closing price of $387.15 this would indicate that there is a potential upside of 47.0%. There is a 50 day moving average of $444.09 while the 200 day moving average is $444.54. The company has a market cap of 11.28B. The current stock price for Targa Resources Corp. is currently 382.56 USD
The potential market cap would be $16,589,172,866 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 93.57 and a 1.86% return on assets.
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets a portfolio of various products that serves a global customer base. The segment is focused on specific segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology and food safety. Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market.
